Emulate launched the Emulate Colon Intestine-Chip Grant Program this week. The program will help researchers begin using Organs-on-Chips technology to study intestinal diseases. The Emulate Colon Intestine-Chip is a physiologically relevant model of the human colon which can be used to study and test potential treatments for inflammatory bowel disease, irritable bowel syndrome, leaky gut, celiac disease, and more.
“Through this program, we look forward to seeing what researchers envision studying with a more predictive model of the human colon, which can leverage mechanical forces to understand the mechanisms of epithelial barrier regulation and investigate the efficacy of therapeutics,” said Lorna Ewart, EVP, Science of Emulate. “We know that the intestinal barrier is critical to human health and that inflammation has been implicated in many diseases. We believe this offering can bring tremendous value to researchers studying cancer biology, the human gut microbiome, as well as the impact of therapeutics in development on disease progression.”
To read more, click here.
Cellino, a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, announced that its CEO Dr. Nabiha Saklayen has been awarded the first Tory Burch Fellowship at the International Genomics Institute (IGI).
The IGI, a research institute at UC Berkeley founded by Nobel laureate Jennifer Doudna, envisions a world in which genome-engineering innovations benefit humanity and are accessible to all. In addition to their scientific efforts, the IGI is committed to advancing public understanding of genome engineering, providing resources for the broader community, and guiding the ethical use of these technologies.
The Tory Burch Fellowship at the IGI supports a woman entrepreneur in leading, growing, and scaling a business in genomics.
“Women are underrepresented in scientific research and also less likely than men to commercialize their discoveries. They face the same barriers that women entrepreneurs typically face, including limiting stereotypes and a lack of access to capital, education and networks. This Fellowship program is the Tory Burch Foundation’s first contribution to the vital issue of women in STEM and we could not be more thrilled to be partnering with brilliant, trailblazing Jennifer Doudna and the Innovative Genomics Institute,” said Tory Burch, CEO at Tory Burch.
To read more, click here.
Heru, a medtech company developing wearable AI-powered vision diagnostics and augmentation software, closed a $30 million Series A round to advance its eye diagnostic and vision correction technology platform.
D1 Capital Partners led the round with participation from SoftBank Ventures Opportunity Fund, Maurice R. Ferre, M.D., Frederic H. Moll, M.D., Krillion Ventures, and a consortium of investor. The company is a spinout of the Bascom Palmer Eye Institute. To read more, click here.
Recuro Health has acquired Minneapolis-based healthcare startup SupDoc, a telehealth company that helps patients to request care and treatment plans from with Minnesota doctors via the patient’s phone or computer.
To read more, click here.
Picture: akindo, Getty Images
